103 AZACITIDINE TREATMENT OF HIGH RISK MDS AND AML, ANALYSIS OF LONG RESPONDING PATIENTS AND PROGNOSTIC FACTORS OF OVERALL SURVIVAL, CZECH MDS GROUP EXPERIENCE. Issue 1 (April 2015) - Jonasova, A.; Cermak, J.; Cervinek, L.; Belohlavkova, P.; Cerna, O.; Kacmarova, K.; Janousova, E.